Thomas Lehmann
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- High Altitude and Hypoxia
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 4
- Genetics 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 14
- Co-authors
- Radek C. SkodaRudolf BrenneisenRenate LooserHui Hao-ShenJakob PasswegMartin SternChristoph NaumannSabine Girsberger
- Journals
- Blood (8 papers)Cancers (3 papers)Annals of Internal Medicine (2 papers)Clinical Infectious Diseases (1 paper)Langmuir (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Thomas Lehmann
56 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Genetics 691
- Hematology 623
- Sensory Systems 137
- Endocrine and Autonomic Systems 149
- Rheumatology 331
Countries citing papers authored by Thomas Lehmann
This map shows the geographic impact of Thomas Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lehmann more than expected).
Fields of papers citing papers by Thomas Lehmann
This network shows the impact of papers produced by Thomas Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lehmann. The network helps show where Thomas Lehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 4 | |
| 8 | 2017 | 22 | |
| 9 | 2015 | 8 | |
| 10 | 2012 | 1 | |
| 11 | 2011 | 2 | |
| 12 | 2009 | 89 | |
| 13 | 2009 | 16 | |
| 14 | Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema | 2006 | 14 |
| 15 | 2002 | 14 | |
| 16 | 2000 | 16 | |
| 17 | 1997 | 4 | |
| 18 | 1997 | 27 | |
| 19 | 1997 | 24 | |
| 20 | 1996 | 23 |
About Thomas Lehmann
Thomas Lehmann is a scholar working on Hematology, Genetics, Toxicology, Rheumatology and Applied Microbiology and Biotechnology, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (12 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Forensic Toxicology and Drug Analysis (4 papers), Kruppel-like factors research (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Cannabis and Cannabinoid Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Genetics (691 citations), Hematology (623 citations), Sensory Systems (137 citations), Endocrine and Autonomic Systems (149 citations) and Rheumatology (331 citations). Thomas Lehmann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Radek C. Skoda, Rudolf Brenneisen, Renate Looser, Hui Hao-Shen, Jakob Passweg, Martin Stern, Christoph Naumann, Sabine Girsberger, C. W. Frank and Ronny Nienhold. Their work appears in journals such as Blood, Cancers, Annals of Internal Medicine, Clinical Infectious Diseases and Langmuir.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.